After Cancer Treatment, Former Ironman Participant Finds Strength Again

Consisting of a 2.4-mile swim, a 112-mile bike ride, and a 26.2-mile run, an Ironman Triathlon is not for the faint of heart — and completing it is a feat worth celebrating. After conquering the race, Dan Luers believed he was ready for whatever life had in store. Nothing could have prepared him for a … Read more

Bone Cancer in Children: What are the Latest Treatment Options?

Medically reviewed by Katherine A. Janeway, MD Cancer affecting the bones may be primary (a cancer that develops within the bone) or metastatic (spreading to bones from elsewhere in the body). Many primary bone tumors are benign (noncancerous), but others are malignant. Treatment options for bone tumors include surgery, chemotherapy, radiation therapy, cryosurgery (freezing cancer … Read more

New Drug Benefits Patients With Myeloma Who Are Resistant to All Therapies

Earlier this year, a novel drug became the first agent to receive U.S. Food and Drug Administration (FDA) approval for patients with multiple myeloma who have exhausted all types of currently available therapies, including proteasome inhibitors, immunomodulatory drugs and monoclonal antibodies. A clinical trial found that 26.2 percent of such patients responded with significant shrinkage … Read more

Basic Research Spurs New Wave of Clinical Trials of Therapies for T-Cell Lymphoma

Medically reviewed by David M. Weinstock, MD, and Eric Jacobsen, MD By banding together to study the basic biology and vulnerabilities of T-cell lymphoma, scientists at several major cancer research centers have sparked a surge of clinical trials of promising treatments for the disease. The string of new trials, some already open, some expected to … Read more

Drug Shows Promise as First Definitive Treatment for Rare Anemia

Medically reviewed by Rachael Grace, MD In the mid-1960s, David G. Nathan, MD, president emeritus of Dana-Farber and, at that time, a hematologist at Boston Children’s Hospital, published some of the first reports on a rare, inherited type of anemia caused by the breakdown of red blood cells because of a lack of a key … Read more

Veteran ‘Thriving’ Years After Advanced Esophageal and Stomach Cancer Diagnosis

It was anything but a routine hospital visit, but Bradley Graham handled his 100th chemotherapy infusion like he has all the rest — with a friendly smile and a steely determination. That’s his makeup. As a principal engineer specializing in submarines and nuclear emergency planning, and a Navy veteran who served more than 20 years … Read more

Aided by Genetic Advances, Pancreatic Cancer Patient Keeps Rolling Along

Anthony Guido sums up his life largely in numbers. He worked construction for more than 30 years, has ridden 500,000-plus miles by motorcycle since turning 18, and shares a combined four children and 16 grandchildren with his wife, Shelly. Guido is proud of it all, but what has him most excited these days is marking … Read more

From a Rare Cancer Gene to a Fundamental Life Process: The Nobel Prize-Winning Research of William G. Kaelin, Jr, MD

In 1992, when he launched his own Dana-Farber laboratory, William G. Kaelin, Jr, MD, was well-positioned to make potentially landmark discoveries. As a physician, he had an encyclopedic knowledge of human diseases, including rare genetic conditions like von Hippel-Lindau (VHL) disease, which is associated with an elevated risk of benign and malignant tumors, particularly in the kidney. … Read more

How Families are Reshaping Shwachman-Diamond Syndrome Research

This article originally appeared on Discoveries, the blog of Boston Children’s Hospital. No one knew the heartache about to unfold when Savannah and Brett Lillywhite first began thinking about having a family 10 years ago. The Lillywhites Savannah and Brett are both the unlikely carriers of a rare condition called Shwachman-Diamond syndrome — SDS for short — … Read more